Skip to main navigation Skip to search Skip to main content

Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC

  • Martin Hasselblatt
  • , Christian Thomas
  • , Aniello Federico
  • , Susanne Bens
  • , Mats Hellström
  • , Olivera Casar-Borota
  • , Uwe Kordes
  • , Julia E. Neumann
  • , Matthias Dottermusch
  • , Fausto J. Rodriguez
  • , Andrea C. Lo
  • , Sylvia Cheng
  • , Glenda Hendson
  • , Juliette Hukin
  • , Christian Hartmann
  • , Arend Koch
  • , David Capper
  • , Reiner Siebert
  • , Werner Paulus
  • , Karolina Nemes
  • Pascal D. Johann, Michael C. Frühwald, Marcel Kool

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant, is a histopathological distinct low-grade lesion encountered in older children and young adults that shows epigenetic similarity with ATRT-MYC and has the potential for malignant progression.

Original languageEnglish
Article numbere12797
Pages (from-to)e12797
Journal Neuropathology and Applied Neurobiology
Volume48
Issue number4
DOIs
Publication statusPublished - Jun 2022

Keywords

  • atypical teratoid/rhabdoid tumour
  • central nervous system low-grade diffusely infiltrative tumour with INI1 deficiency
  • DNA methylation profiling
  • neuropathology
  • SMARCB1 Protein/genetics
  • Young Adult
  • Teratoma
  • Epigenesis, Genetic
  • Humans
  • Rhabdoid Tumor/pathology
  • Child

Fingerprint

Dive into the research topics of 'Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC'. Together they form a unique fingerprint.

Cite this